MC38-hPD-L1(2)
Strain Information
表現型データ
Figure 1. Expression of human PD-L1 on MC38-hPD-L1 cells was confirmed by flow cytometry.
MC38-hPD-L1 cells and wild type MC38 cells were stained with species-specific anti-PD-L1 antibodies. FACS analysis shows that human PD-L1 but not mouse PD-L1 was exclusively detectable on MC38-hPD-L1 cells.
Figure 2. In vivo tumor growth curves in humanized MC38-hPD-L1 syngeneic model.
BALB/c mice were subcutaneously injected 1×106 MC38-hPD-L1 cells compared with wild type MC38 cells as control. Tumor growth was monitored by measuring tumor size from day 3 after subcutaneous implantation.
Data shows that there were no significant differences between MC38-hPD-L1 cells and wild type MC38 cells in either tumorigenicity or tumor growth.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
詳細